SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-042392
Filing Date
2004-03-15
Accepted
2004-03-15 17:08:59
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 1773031
3 SUBSIDIARIES OF THE REGISTRANT dex8.htm EX-8 18706
4 CONSENT OF KESSELMAN & KESSELMAN dex101.htm EX-10.1 2287
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex12i.htm EX-12.I 8067
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex12ii.htm EX-12.II 8111
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex13.htm EX-13 4175
  Complete submission text file 0001193125-04-042392.txt   1816601
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-16174 | Film No.: 04670353
SIC: 2834 Pharmaceutical Preparations